Aphena provides clients with a full range of solutions to address their pharmaceutical manufacturing and packaging requirements. With our continued investment in technology, advanced packaging systems and rigorous cost control, we can deliver solutions that are highly cost effective as well as comprehensive. Major markets include Pharmaceutical (Rx and OTC), Dietary Supplement, Animal Health, Consumer Products, and Medical Devices. Our facilities are located in Maryland, Tennessee, New Jersey and New York.
Suhasini Sharma, Sciformix Corporation ||September 11, 2015 Global biologics market will expand to $250 billion annually by 2020, with biosimilars and non-original biologics commanding 4-10% of that market
Patricia Hurley, Joan Boren and Costantino Congiatu, PPD||June 2, 2015 More than $60 billion worth of patents on biological products are expiring before 2020, representing a major opportunity for the pharmaceutical industry.
Stephanie Mowery, Sherri Rinker, Franklin Spriggs and Bo Kowalcyk , AIT Bioscience||June 2, 2015 Moving forward clinical studies will have to include a comparative assessment of
pharmacokinetics and immunogenicity to the original reference biologic drug
Tjebbe van der Meer, Sartorius Stedim Biotech||June 2, 2015 Continuous improvements in growth media and cell line viability have resulted in increased biomass concentrations in biopharmaceutical production processes, making the downstream purification step more challenging. Body feed filtration has proven to be a successful method of solving similar issues in other industries. This robust technology is now available as a harvesting solution for biotechnology applications.
Walt Berghahn , Healthcare Compliance Packaging Council (HCPC)||June 2, 2015 Spurred by several trends including the patent cliff, new product launches and changes in healthcare, the contract packaging market is looking at sustained growth in the years ahead
Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015 As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important